These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 9392928

  • 1. The approach to treatment of invasive pneumococcal disease in the 1990s.
    Knapp KM, Schutze GE.
    J Ark Med Soc; 1997 Nov; 94(6):263-6. PubMed ID: 9392928
    [Abstract] [Full Text] [Related]

  • 2. [Pneumococcal antibiotic resistance].
    Moreillon P, Wenger A, Caldelari I.
    Rev Med Suisse Romande; 2000 Aug; 120(8):651-9. PubMed ID: 11028185
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of antimicrobial drug-resistant Streptococcus pneumoniae in Washington State.
    Frick PA, Black DJ, Duchin JS, Deliganis S, McKee WM, Fritsche TR.
    West J Med; 1998 Dec; 169(6):364-9. PubMed ID: 9866434
    [Abstract] [Full Text] [Related]

  • 4. Penicillin-nonsusceptible Streptococcus pneumoniae infections in children.
    Lu CY, Lee PI, Hsueh PR, Chang SC, Chiu TF, Lin HC, Lee CY, Huang LM.
    J Microbiol Immunol Infect; 1999 Sep; 32(3):179-86. PubMed ID: 10637716
    [Abstract] [Full Text] [Related]

  • 5. Antibiotic susceptibility of invasive Streptococcus pneumoniae in Wisconsin, 1999.
    Belongia EA, Proctor M, Vandermause M, Ahrabi-Fard S, Knobloch MJ, Keller P, Bergs R, Chyou PH, Davis JP.
    WMJ; 2000 Aug; 99(5):55-9. PubMed ID: 11043072
    [Abstract] [Full Text] [Related]

  • 6. [Effectiveness of the antibiotics chloramphenicol and rifampin in the treatment of Streptococcus pneumoniae-induced meningitis and systemic infections].
    Hernández M, Mejía GI, Trujillo H, Robledo J.
    Biomedica; 2003 Dec; 23(4):456-61. PubMed ID: 14968923
    [Abstract] [Full Text] [Related]

  • 7. Pneumococcal susceptibility to meropenem in a mid-south children's hospital.
    Buckingham SC, Davis Y, English BK.
    South Med J; 2002 Nov; 95(11):1293-6. PubMed ID: 12539996
    [Abstract] [Full Text] [Related]

  • 8. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO, Wald ER, Bradley JS, Barson WJ, Kaplan SL, United States Pediatric Multicenter Pneumococcal Surveillance Study Group.
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [Abstract] [Full Text] [Related]

  • 9. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L.
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [Abstract] [Full Text] [Related]

  • 10. [Antibiotic resistance in pneumococci].
    Moreillon P, Wenger A.
    Schweiz Med Wochenschr; 1996 Feb 17; 126(7):255-63. PubMed ID: 8720323
    [Abstract] [Full Text] [Related]

  • 11. Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine.
    Garbutt J, Rosenbloom I, Wu J, Storch GA.
    Pediatrics; 2006 Jun 17; 117(6):e1087-94. PubMed ID: 16740811
    [Abstract] [Full Text] [Related]

  • 12. [Sensitivity of Streptococcus pneumoniae to antimicrobial drugs].
    Mihajlović-Ukropina M, Milutinović M.
    Med Pregl; 1998 Jun 17; 51(3-4):169-73. PubMed ID: 9611963
    [Abstract] [Full Text] [Related]

  • 13. Streptococcus pneumoniae: bacteremia in an era of penicillin resistance.
    Castillo EM, Rickman LS, Brodine SK, Ledbetter EK, Kelly C.
    Am J Infect Control; 2000 Jun 17; 28(3):239-43. PubMed ID: 10840344
    [Abstract] [Full Text] [Related]

  • 14. Surveillance for penicillin-nonsusceptible Streptococcus pneumoniae--New York City, 1995.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1997 Apr 11; 46(14):297-9. PubMed ID: 9132581
    [Abstract] [Full Text] [Related]

  • 15. A significant increase in antimicrobial resistance among pneumococci causing invasive disease in New Zealand.
    Brett MS, Martin DR.
    N Z Med J; 1999 Apr 09; 112(1085):113-5. PubMed ID: 10326798
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of susceptibility status of invasive pneumococcal isolates to various antibiotics and risk factors associated with invasive penicillin-nonsusceptible pneumococcal infection: Bangkok 1997-1998.
    Chokephaibulkit K, Srifuengfung S, Mingbanjerdsuk J, Tosasuk K, Vanprapar N, Chearskul S, Dhiraputra C.
    Southeast Asian J Trop Med Public Health; 2000 Sep 09; 31(3):498-505. PubMed ID: 11289009
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN, Fritsche TR, Sader HS.
    Diagn Microbiol Infect Dis; 2005 Jun 09; 52(2):129-33. PubMed ID: 15964501
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.
    Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB.
    Antimicrob Agents Chemother; 2001 Jun 09; 45(6):1721-9. PubMed ID: 11353617
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of penicillin-resistant Streptococcus pneumoniae--Connecticut, 1992-1993.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1994 Apr 01; 43(12):216-7, 223. PubMed ID: 8127327
    [Abstract] [Full Text] [Related]

  • 20. Penicillin resistant Streptococcus pneumoniae isolates in Harare, Zimbabwe.
    Simango C, Mvududu F.
    Cent Afr J Med; 1999 Apr 01; 45(4):100-2. PubMed ID: 10746390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.